http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526808-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2012526808-A |
titleOfInvention | ((1S, 2S, 4R) -4- {4-[(1S) -2,3-dihydro-1H-inden-1-ylamino] -7H-pyrrolo [2,3-D] pyrimidin-7-yl} 2-hydroxycyclopentyl) methyl sulfamate hydrochloride |
abstract | A compound of formula (I), a crystalline form thereof, and a solvate thereof, and a pharmaceutically effective amount of a compound of formula (I), or a crystalline form thereof, or a solvate thereof, and a pharmaceutically acceptable carrier or A pharmaceutical composition comprising a diluent and a formula for treating a patient suffering from or susceptible to a pathological condition, including cancer, which can be alleviated by inhibiting E1 activating enzymes, particularly NAE The use of a compound of (I), or a crystalline form thereof, or a solvate thereof is disclosed. |
priorityDate | 2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.